ASTS
AST SpaceMobile, Inc.
ASTS lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to grow, though they disagree widely on how much.
SONM
DNA X, Inc.
There isn't enough reported data to score SONM yet.
ASTS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
ASTS's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
SONM Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Weak | |
| Unavailable | |
| Strong |
SONM's balance sheet is currently strong, and its revenue is stable, but its profitability is weak. There isn't enough data to rate its cash flow.
ASTS PE Valuation
ASTS has no meaningful PE right now: it lost money over the past year.
SONM PE Valuation
SONM has no meaningful PE right now: it lost money over the past year.
ASTS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect ASTS's losses to grow, with revenue growing. However, they disagree widely on these estimates.
SONM Forward outlook
There aren't enough analyst estimates for SONM to show an outlook.
ASTS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.15 | -$0.91 |
| Q2 2026 | -$2.16 | -$0.27 |
| Q1 2026 | -$1.80 | +$0.19 |
| Q4 2025 | -$1.34 | +$0.61 |
| Q3 2025 | -$1.24 | +$0.88 |
| Q2 2025 | -$1.89 | -$0.64 |
| Q1 2025 | -$1.99 | -$1.01 |
| Q4 2022 | -$0.58 | -$0.21 |
ASTS is still losing money, but far less than before: $2.15 per share over the past year, against $5.76 at its worst in mid-2021.
SONM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$23.78 | +$90.70 |
| Q1 2026 | -$37.08 | +$88.56 |
| Q4 2025 | -$40.65 | +$99.03 |
| Q3 2025 | -$109.95 | -$57.21 |
| Q2 2025 | -$114.48 | -$72.90 |
| Q1 2025 | -$125.64 | -$111.24 |
| Q4 2024 | -$139.68 | -$139.68 |
| Q3 2024 | -$52.74 | -26470% |
SONM is still losing money, but far less than before: $23.78 per share over the past year, against $2,664.00 at its worst in early 2020.
ASTS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $42.3M | +187% |
| Q2 2026 | $31.5M | +2627% |
| Q1 2026 | $14.7M | +1952% |
| Q4 2025 | $54.3M | +2731% |
| Q3 2025 | $14.7M | +1240% |
| Q2 2025 | $1.2M | +28% |
| Q1 2025 | $718K | +44% |
| Q3 2022 | $4.2M | +70% |
ASTS has the stronger quarterly revenue trend. Revenue is up 187% for ASTS versus up 7.9% for SONM.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -415% | +694 points |
| Q2 2026 | -948% | +10744 points |
| Q1 2026 | -1686% | +7083 points |
| Q4 2025 | -175% | +2446 points |
| Q3 2025 | -1109% | +4850 points |
| Q2 2025 | -11692% | -4693 points |
| Q1 2025 | -8769% | +2331 points |
| Q4 2024 | -2621% | N/A |
ASTS's operating margin was โ415% last quarter, up 694 points from the same quarter a year ago.
SONM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2025 | $16.2M | +7.9% |
| Q2 2025 | $11.2M | -2.8% |
| Q1 2025 | $16.7M | -0.3% |
| Q4 2024 | $15M | +12% |
| Q3 2024 | $15M | -46% |
| Q2 2024 | $11.5M | -57% |
| Q1 2024 | $16.8M | -35% |
| Q4 2023 | $13.4M | -44% |
SONM's revenue is recovering but still below its 2019 peak: $16M last quarter, up 7.9% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2025 | -25% | -8.7 points |
| Q2 2025 | -60% | -4 points |
| Q1 2025 | 3.9% | +20 points |
| Q4 2024 | -148% | -138 points |
| Q3 2024 | -16% | -18 points |
| Q2 2024 | -56% | -59 points |
| Q1 2024 | -16% | -17 points |
| Q4 2023 | -9.3% | -5 points |
SONM's operating margin was โ25% last quarter, down 8.7 points from the same quarter a year ago.
ASTS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$464.2M | -$161.4M |
| Q2 2026 | -$694.8M | -$341.1M |
| Q1 2026 | -$309.7M | -$160.7M |
| Q4 2025 | -$330.7M | -$220.3M |
| Q3 2025 | -$302.9M | -$239.1M |
| Q2 2025 | -$353.6M | -$315.3M |
| Q1 2025 | -$149M | -$61.3M |
| Q4 2024 | -$110.5M | -$63.2M |
SONM has the stronger cash trend. Its trailing FCF is up 7.7% versus its history, compared with ASTS at down 363%.
SONM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2025 | -$2M | +$2.5M |
| Q4 2024 | -$4.5M | -$4.2M |
| Q3 2024 | -$554K | -$249K |
| Q4 2023 | -$363K | +$1.9M |
| Q3 2023 | -$305K | +$10M |
| Q4 2022 | -$2.2M | +$15.4M |
| Q4 2021 | -$17.6M | -$7.9M |
| Q4 2020 | -$9.7M | -$4.9M |
SONM has burned cash in most quarters: โ$12M over the past year, against โ$5M the year before.
ASTS Net Leverage
ASTS's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
SONM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2023 | -3.5x | Net Cash |
| Q3 2023 | -2.6x | Net Cash |
| Q2 2023 | -7.7x | Net Cash |
SONM has more cash than debt.
ASTS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.1 | Neutral |
| Stochastic | 11.9 | Oversold |
ASTS's weekly RSI is 34 (neutral) and its Stochastic is 12 (oversold).
SONM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.0 | Neutral |
| Stochastic | 7.9 | Oversold |
SONM's weekly RSI is 37 (neutral) and its Stochastic is 8 (oversold).
ASTS PE vs Technology Sector
ASTS has no meaningful PE right now: it lost money over the past year.
SONM PE vs Technology Sector
| Metric | SONM | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 28x | โ |
SONM has no meaningful PE right now: it lost money over the past year.
ASTS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $44.9 | 23% below |
| 20 week MA | $57.1 | 40% below |
| 50 week MA | $75.5 | 54% below |
| 100 week MA | $57.8 | 40% below |
| 200 week MA | $33.6 | 2.8% above |
ASTS has the edge over SONM on trend strength, trading above more of its moving averages.
SONM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.15 | 24% below |
| 20 week MA | $3.34 | 29% below |
| 50 week MA | $4.11 | 42% below |
| 100 week MA | $15.1 | 84% below |
| 200 week MA | $65.4 | 96% below |
SONM is in a downtrend: it's below all five of its weekly moving averages, and 96% below its 200-week average.
ASTS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.87 | $13.4 | +36% |
| 2021 | $13.4 | $8.71 | -35% |
| 2022 | $8.71 | $3.97 | -54% |
| 2023 | $3.97 | $6.03 | +52% |
| 2024 | $6.03 | $22.9 | +280% |
| 2025 | $22.9 | $72.0 | +214% |
| 2026 YTD | $72.0 | $34.5 | -52% |
ASTS's yearly returns have swung widely, from +280% in 2024 to โ54% in 2022. It's down 52% so far in 2026.
SONM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $6,606.0 | $1,165.3 | -82% |
| 2021 | $1,165.3 | $180.0 | -85% |
| 2022 | $180.0 | $79.2 | -56% |
| 2023 | $79.2 | $132.3 | +67% |
| 2024 | $132.3 | $55.4 | -58% |
| 2025 | $55.4 | $3.30 | -94% |
| 2026 YTD | $3.30 | $2.38 | -28% |
SONM has the edge over ASTS on returns for 2026, with the stronger performance.